CRH shares near all-time highs as earnings jump, Polymetal bumps up its dividend but blows its capex budget, Hays restarts payouts as recruitment starts to bounce back, AstraZeneca’s Forxiga drug is approved in Japan, and Hunting cuts profits expectations.